Skip to content

Effectiveness and Safety of Homeopathic Arnica 200C and Symphytum 30C on Bone Healing in Elderly Patients with Closed Fracture: A Randomized Controlled Trial

Effectiveness and Safety of Homeopathic Arnica 200C and Symphytum 30C on Bone Healing in Elderly Patients with Closed Fracture: A Randomized Controlled Trial

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
TCTR
Registry ID
TCTR20260403006
Enrollment
40
Registered
2026-04-03
Start date
2020-03-03
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Closed bone fractures in elderly patients, particularly fractures of the upper extremities including shoulder, arm, elbow, wrist, hand, and finger. Bone fractures in older adults are commonly associated with osteoporosis, increased risk of falls, pain, delayed bone healing, and reduced functional ability. Delayed bone healing and prolonged recovery may lead to complications such as decreased mobility and reduced quality of life. This study focuses on elderly patients with closed fractures who re

Interventions

Participants in the experimental group will receive homeopathic medicines Arnica 200C and Symphytum 30C in addition to standard medical treatment for closed fractures. The medicines are prepared as su
Experimental Drug,Placebo Comparator Drug
Arnica 200C and Symphytum 30C,Placebo

Sponsors

Department of Thai Traditional and Alternative Medicine, Ministry of Public Health, Thailand
Lead Sponsor

Eligibility

Sex/Gender
All
Age
60 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1.Patients aged 60 to 75 years, 2. Male or female patients who voluntarily agree to participate in the study and provide written informed consent, 3. Patients able to communicate in Thai language or have a caregiver to assist with medication administration and follow up, 4. Patients diagnosed with closed fracture of the upper extremities including shoulder arm elbow wrist hand or finger confirmed by an orthopedic physician, 5. Patients with fractures managed with non surgical standard treatment

Exclusion criteria

Exclusion criteria: 1.Adverse symptoms related to Arnica 200C or Symphytum 30C such as severe pain, 2. Patients requiring hemodialysis, 3. History of chronic liver disease or chronic kidney disease, 4. Fracture involving skull or thoracic region, 5. Abnormal liver or renal function based on physician diagnosis and laboratory tests, 6. History of severe allergic reaction

Design outcomes

Primary

MeasureTime frame
Bone healing 4 weeks Radiographic evaluation of bone healing stage using X ray classified as no callus callus formation or consolidation

Secondary

MeasureTime frame
Pain score Baseline week 1 week 2 week 3 and week 4 Pain intensity assessed using numerical rating scale,Analgesic use 4 weeks Number of times and total amount of analgesic medication used during follow up period

Countries

Thailand

Contacts

Public ContactKulthanit Wanaratna

Ministry of Public Health

kulthanitw@gmail.com02 591 7007

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 10, 2026